Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2011-12-20

AUTHORS

Guido Kobbe , Rainer Haas

ABSTRACT

High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing’s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called “poor mobilizers.” This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization. More... »

PAGES

247-262

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13

DOI

http://dx.doi.org/10.1007/978-1-4614-1960-0_13

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008554651


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "Guido", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "Rainer", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2011-12-20", 
    "datePublishedReg": "2011-12-20", 
    "description": "High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing\u2019s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called \u201cpoor mobilizers.\u201d This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization.", 
    "editor": [
      {
        "familyName": "Fruehauf", 
        "givenName": "Stefan", 
        "type": "Person"
      }, 
      {
        "familyName": "Zeller", 
        "givenName": "W. Jens", 
        "type": "Person"
      }, 
      {
        "familyName": "Calandra", 
        "givenName": "Gary", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4614-1960-0_13", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4614-1959-4", 
        "978-1-4614-1960-0"
      ], 
      "name": "Novel Developments in Stem Cell Mobilization", 
      "type": "Book"
    }, 
    "keywords": [
      "stem cell mobilization", 
      "blood stem cell mobilization", 
      "high-dose therapy", 
      "cell mobilization", 
      "solid tumors", 
      "G-CSF", 
      "autologous hematopoietic stem cell transplantation", 
      "high-risk hematologic malignancies", 
      "hematopoietic stem cell transplantation", 
      "blood stem cell collection", 
      "rare solid tumors", 
      "stem cell transplantation", 
      "CXCR4 antagonist plerixafor", 
      "germ cell tumors", 
      "hematopoietic stem cell mobilization", 
      "blood stem cells", 
      "use of plerixafor", 
      "stem cell collection", 
      "recurrent disease", 
      "cell transplantation", 
      "cytotoxic therapy", 
      "mobilization regimens", 
      "cell tumors", 
      "poor mobilizers", 
      "hematologic malignancies", 
      "Ewing's sarcoma", 
      "patients", 
      "experimental agents", 
      "GM-CSF", 
      "tumors", 
      "cell collection", 
      "plerixafor", 
      "therapy", 
      "young adults", 
      "Recent evidence", 
      "sarcoma", 
      "steady-state hematopoiesis", 
      "current literature", 
      "stem cells", 
      "mobilization", 
      "regimens", 
      "transplantation", 
      "malignancy", 
      "neuroblastoma", 
      "medulloblastoma", 
      "disease", 
      "extensive pretreatment", 
      "adults", 
      "children", 
      "adolescents", 
      "hematopoiesis", 
      "mobilizers", 
      "pretreatment", 
      "cells", 
      "agents", 
      "evidence", 
      "use", 
      "combination", 
      "literature", 
      "addition", 
      "types", 
      "collection", 
      "chapter", 
      "alternative way", 
      "way"
    ], 
    "name": "Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization", 
    "pagination": "247-262", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008554651"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4614-1960-0_13"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4614-1960-0_13", 
      "https://app.dimensions.ai/details/publication/pub.1008554651"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_226.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4614-1960-0_13"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'


 

This table displays all metadata directly associated to this object as RDF triples.

141 TRIPLES      22 PREDICATES      88 URIs      81 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4614-1960-0_13 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N84a313bebaf4428d9ac7cd2be8a10477
4 schema:datePublished 2011-12-20
5 schema:datePublishedReg 2011-12-20
6 schema:description High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing’s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called “poor mobilizers.” This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization.
7 schema:editor Nd30a7a64d597426890bbdf9495039728
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N81219b64c9634e77b5d0e2a5cb214447
11 schema:keywords CXCR4 antagonist plerixafor
12 Ewing's sarcoma
13 G-CSF
14 GM-CSF
15 Recent evidence
16 addition
17 adolescents
18 adults
19 agents
20 alternative way
21 autologous hematopoietic stem cell transplantation
22 blood stem cell collection
23 blood stem cell mobilization
24 blood stem cells
25 cell collection
26 cell mobilization
27 cell transplantation
28 cell tumors
29 cells
30 chapter
31 children
32 collection
33 combination
34 current literature
35 cytotoxic therapy
36 disease
37 evidence
38 experimental agents
39 extensive pretreatment
40 germ cell tumors
41 hematologic malignancies
42 hematopoiesis
43 hematopoietic stem cell mobilization
44 hematopoietic stem cell transplantation
45 high-dose therapy
46 high-risk hematologic malignancies
47 literature
48 malignancy
49 medulloblastoma
50 mobilization
51 mobilization regimens
52 mobilizers
53 neuroblastoma
54 patients
55 plerixafor
56 poor mobilizers
57 pretreatment
58 rare solid tumors
59 recurrent disease
60 regimens
61 sarcoma
62 solid tumors
63 steady-state hematopoiesis
64 stem cell collection
65 stem cell mobilization
66 stem cell transplantation
67 stem cells
68 therapy
69 transplantation
70 tumors
71 types
72 use
73 use of plerixafor
74 way
75 young adults
76 schema:name Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization
77 schema:pagination 247-262
78 schema:productId N1b0b53ae531441518d9fd05861707ead
79 Nfa913ea9183044cba521e874ee6d9b3c
80 schema:publisher N2a946d05daa64a729eecbf7935e8773e
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008554651
82 https://doi.org/10.1007/978-1-4614-1960-0_13
83 schema:sdDatePublished 2022-10-01T06:54
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N2ea0e3a38b2c4903aa0c7f5580c86366
86 schema:url https://doi.org/10.1007/978-1-4614-1960-0_13
87 sgo:license sg:explorer/license/
88 sgo:sdDataset chapters
89 rdf:type schema:Chapter
90 N09a9a1d900bf4d18af4e78476c1d46c1 rdf:first N2a8e17999f614b539ed1aa12cdf82eac
91 rdf:rest rdf:nil
92 N1b0b53ae531441518d9fd05861707ead schema:name doi
93 schema:value 10.1007/978-1-4614-1960-0_13
94 rdf:type schema:PropertyValue
95 N2a8e17999f614b539ed1aa12cdf82eac schema:familyName Calandra
96 schema:givenName Gary
97 rdf:type schema:Person
98 N2a946d05daa64a729eecbf7935e8773e schema:name Springer Nature
99 rdf:type schema:Organisation
100 N2ea0e3a38b2c4903aa0c7f5580c86366 schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N58b37ee5bec543f29305733a19fccf19 rdf:first Na7a69ca40d194cd2a719230a9606846d
103 rdf:rest N09a9a1d900bf4d18af4e78476c1d46c1
104 N6bbbda37737c427da17cf21423fe1d7a rdf:first sg:person.01127414674.14
105 rdf:rest rdf:nil
106 N81219b64c9634e77b5d0e2a5cb214447 schema:isbn 978-1-4614-1959-4
107 978-1-4614-1960-0
108 schema:name Novel Developments in Stem Cell Mobilization
109 rdf:type schema:Book
110 N84a313bebaf4428d9ac7cd2be8a10477 rdf:first sg:person.01164073234.53
111 rdf:rest N6bbbda37737c427da17cf21423fe1d7a
112 Na7a69ca40d194cd2a719230a9606846d schema:familyName Zeller
113 schema:givenName W. Jens
114 rdf:type schema:Person
115 Nd30a7a64d597426890bbdf9495039728 rdf:first Nd8fbe3a722f5489797308135ad0d1cfb
116 rdf:rest N58b37ee5bec543f29305733a19fccf19
117 Nd8fbe3a722f5489797308135ad0d1cfb schema:familyName Fruehauf
118 schema:givenName Stefan
119 rdf:type schema:Person
120 Nfa913ea9183044cba521e874ee6d9b3c schema:name dimensions_id
121 schema:value pub.1008554651
122 rdf:type schema:PropertyValue
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
127 schema:name Cardiorespiratory Medicine and Haematology
128 rdf:type schema:DefinedTerm
129 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.411327.2
130 schema:familyName Haas
131 schema:givenName Rainer
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
133 rdf:type schema:Person
134 sg:person.01164073234.53 schema:affiliation grid-institutes:grid.411327.2
135 schema:familyName Kobbe
136 schema:givenName Guido
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
138 rdf:type schema:Person
139 grid-institutes:grid.411327.2 schema:alternateName Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany
140 schema:name Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany
141 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...